New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

In 2023, Novo Nordisk was the most valuable company in Europe, surpassing LVMH on the back of soaring demand for Ozempic and Wegovy. Today, the Danish company has lost its grip on the anti-obesity ...

Ozempic, a type 2 diabetes treatment, presents investment opportunities via Novo Nordisk stock. Projected GLP-1 market growth to almost $160 billion by early the 2030s indicates long-term sector ...

Lizzo is finally opening up on the role Ozempic played during her massive weight loss journey.. The 37-year-old “About Damn Time” singer, who initially became a symbol of body positivity as a ...

As a more tolerable treatment, it may overtake Ozempic in the weight loss market. "And then there is a third hormone, glucagon," said Kumar. "Paradoxically, ...

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic. ... medications that they hope will be even more powerful than those currently on the market.